Beijing Diagreat Biotechnology
Beijing, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
Focuses on rapid diagnostic kits for infectious diseases like HIV and hepatitis.
Infectious DiseaseDiagnostics
Technology Platform
Specializes in immunochromatographic (lateral flow) and PCR-based platforms for rapid and accurate detection of infectious pathogens.
Opportunities
Increased demand for decentralized and rapid testing in response to pandemic preparedness initiatives.
Risk Factors
Revenue volatility dependent on government tender cycles and outbreak patterns for specific diseases.
Competitive Landscape
A niche player in infectious disease diagnostics, competing on product menu and cost in a segment with several specialized rivals.